Showing results (31-40 of 340) with videos related to

Sort By:
Pageof 34
Journal of the Chinese Medical Association : JCMA|June 5, 2018
A real world cost effectiveness analysis of interferon-based therapy for HCV naïve super-respondersPei-Chien Tsai, Ta-Wei Liu, Chung-Feng Huang, et al.
The Kaohsiung Journal of Medical Sciences|December 31, 2024
Safety of transarterial chemoembolization on renal function in combined hepatocellular carcinoma and chronic kidney disease patientsZu-Yau Lin, Ming-Lun Yeh, Po-Cheng Liang, et al.
Hepatology International|November 11, 2010
Hepatitis B virus genotyping by enzyme-linked immunosorbent assay in TaiwanShu-Fen Liu, Meng-Hsuan Hsieh, Nai-Jen Hou, et al.
American Journal of Epidemiology|May 16, 2014
Cirrhosis as a risk factor for tuberculosis infection--a nationwide longitudinal study in TaiwanYi-Ting Lin, Ping-Hsun Wu, Chun-Yu Lin, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 24, 2022
Clinical characteristics and treatment outcomes of SARS-CoV-2 delta variant outbreak, Pingtung, Taiwan, June 2021Tyng-Yuan Jang, Hsin-Hui Wang, Chung-Feng Huang, et al.
Journal of Translational Medicine|March 13, 2024
Systematic integration of molecular and clinical approaches in HCV-induced hepatocellular carcinomaCiniso Sylvester Shabangu, Wen-Hsiu Su, Chia-Yang Li, et al.
The Kaohsiung Journal of Medical Sciences|July 6, 2024
Viral hepatitis moderates the impact of TGFB1 on neurocognitive impairmentWei-Chia Tsao, Rwei-Ling Yu, Chi-Ting Li, et al.
Pathogens (Basel, Switzerland)|October 23, 2021
The Prevalence and Serological Association of Hepatitis D Virus Genotypes in TaiwanKeva Joseph, Ciniso Sylvester Shabangu, Tyng-Yuan Jang, et al.
Journal of Gastroenterology and Hepatology|October 20, 2015
Long-term efficacy of Peg-Interferon/Ribavirin with and without Lamivudine therapy for HBeAg-positive hepatitis B and C dual infectionMing-Lun Yeh, Ming-Yen Hsieh, Ching-I Huang, et al.
Pageof 34